Pay in 4 interest-free payments of $5.05 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Exenatide twice daily versus glimepiride for prevention of glycaemic deterioration in patients with type 2 diabetes with metformin failure (EUREXA): an open-label, randomised controlled trial
There are reports that inhalation of glutathione may trigger asthma attacks
Ready-to-drink formats are being adopted across major hospitals in the United States, Germany, and Japan
Low-quality evidence from another trial that compared the effect of ALCAR (1.5 g/day) with that of methylcobalamin (1.5 mg/day) for 24 weeks suggested no difference between treatments regarding the extent of functional disability (using the Neuropathy Disability Scale) or measures of symptom quality and severity (using the Neuropathy Symptom Scale) (89)
A critical review on modulators of multidrug resistance protein 1 in cancer cells
US$ 20.46
US$ 28.17
US$ 21.47
US$ 24.57
